相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiotoxicity screening: a review of rapid-throughput in vitro approaches
Xichun Li et al.
ARCHIVES OF TOXICOLOGY (2016)
Genetic screening in acquired long QT syndrome? CAUTION: proceed carefully
Ahmad S. Amin et al.
EUROPEAN HEART JOURNAL (2016)
The genetics underlying acquired long QT syndrome: impact for genetic screening
Hideki Itoh et al.
EUROPEAN HEART JOURNAL (2016)
WITHDRAWN-a resource for withdrawn and discontinued drugs
Vishal B. Siramshetty et al.
NUCLEIC ACIDS RESEARCH (2016)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
Christopher Southan et al.
NUCLEIC ACIDS RESEARCH (2016)
Human engineered heart tissue as a model system for drug testing
Alexandra Eder et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes
Ravi Vaidyanathan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
High-throughput drug profiling with voltage-and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes
Stephane Bedut et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction
Daniela Malan et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform
Chris Denning et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Beat-to-Beat Variability in Preload Unmasks Latent Risk of Torsade de Pointes in Anesthetized Chronic Atrioventricular Block Dogs
Thom R. G. Stams et al.
CIRCULATION JOURNAL (2016)
Allosteric Modulation of Kv11.1 (hERG) Channels Protects Against Drug-Induced Ventricular Arrhythmias
Zhiyi Yu et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2016)
Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
Igho J. Onakpoya et al.
CRITICAL REVIEWS IN TOXICOLOGY (2016)
Cystic fibrosis: a model system for precision medicine
Stacey L. Martiniano et al.
CURRENT OPINION IN PEDIATRICS (2016)
Generation and purification of human stem cell-derived cardiomyocytes
Verena Schwach et al.
DIFFERENTIATION (2016)
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
Luca Sala et al.
EMBO MOLECULAR MEDICINE (2016)
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
Valentina Mercurio et al.
JOURNAL OF CARDIAC FAILURE (2016)
Predicting the Unpredictable Drug-Induced QT Prolongation and Torsades de Pointes
Peter J. Schwartz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction
Roseanne Raphael et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
A high-content platform to characterise human induced pluripotent stem cell lines
Andreas Leha et al.
METHODS (2016)
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge et al.
NATURE MEDICINE (2016)
The cancer's gone, but did chemotherapy damage your heart?
Milena Bellin et al.
NATURE REVIEWS CARDIOLOGY (2016)
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
Ian Y. Chen et al.
NATURE REVIEWS CARDIOLOGY (2016)
Evolution of strategies to improve preclinical cardiac safety testing
Gary Gintant et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Pluripotent stem cells in disease modelling and drug discovery
Yishai Avior et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Experimentally-Based Computational Investigation into Beat-To-Beat Variability in Ventricular Repolarization and Its Response to Ionic Current Inhibition
E. Pueyo et al.
PLOS ONE (2016)
Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues
Stephanie M. Ravenscroft et al.
TOXICOLOGICAL SCIENCES (2016)
OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology
Aleksandra Klimas et al.
NATURE COMMUNICATIONS (2016)
Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
Agnes Maillet et al.
SCIENTIFIC REPORTS (2016)
Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem Cells
Renjun Zhu et al.
SCIENTIFIC REPORTS (2016)
Safety pharmacology studies using EFP and impedance
Alison Obergrussberger et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging
Graham T. Dempsey et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia - Effects of 7 reference compounds at 10 facilities
Takashi Kitaguchi et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation
Icilio Cavero et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
William J. Crumb et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential
Aija Kyttala et al.
STEM CELL REPORTS (2016)
Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
Jukka Kuusela et al.
SPRINGERPLUS (2016)
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm
Bernard Fermini et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Drug-induced mitochondrial dysfunction and cardiotoxicity
Zoltan V. Varga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine
Paul W. Burridge et al.
ANNUAL REVIEW OF GENETICS, VOL 49 (2015)
Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro - Correlation between contraction force and electrophysiology
Marcelo C. Ribeiro et al.
BIOMATERIALS (2015)
Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block
M. Paci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
M. J. Cross et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Voltage-gated ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial
John McNeish et al.
CELL STEM CELL (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Sensing Cardiac Electrical Activity With a Cardiac Myocyte-Targeted Optogenetic Voltage Indicator
Mei-Ling Chang Liao et al.
CIRCULATION RESEARCH (2015)
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp
Claudia Altomare et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2015)
Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology
Harsha D. Devalla et al.
EMBO MOLECULAR MEDICINE (2015)
Regulating the therapeutic translation of regenerative medicine
Maude L. Cuchiara et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells
Jong J. Kim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Human induced pluripotent stem cell (hiPSC) derived cardiomyocytes to understand and test cardiac calcium handling: A glass half full
Hyun Seok Hwang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Induced pluripotent stem cell-derived cardiac myocytes to understand and test calcium handling: Pie in the sky?
Christopher Kane et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories
Hyun Seok Hwang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells
Daniel Paull et al.
NATURE METHODS (2015)
Cardiotoxicity of anticancer treatments
Michael S. Ewer et al.
NATURE REVIEWS CARDIOLOGY (2015)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models (vol 10, e0125366, 2015)
Kirsi Penttinen et al.
PLOS ONE (2015)
Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness
Alexandre J. S. Ribeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
Christiaan C. Veerman et al.
STEM CELLS AND DEVELOPMENT (2015)
Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales
Nathaniel Huebsch et al.
TISSUE ENGINEERING PART C-METHODS (2015)
Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes
Philippe Beauchamp et al.
TISSUE ENGINEERING PART C-METHODS (2015)
High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds
Hua Rong Lu et al.
TOXICOLOGICAL SCIENCES (2015)
Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes
Dongrui Ma et al.
STEM CELL RESEARCH & THERAPY (2015)
Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function
Matthew J. Birket et al.
CELL REPORTS (2015)
An integrated platform for simultaneous multi-well field potential recording and Fura-2-based calcium transient ratiometry in human induced pluripotent stem cell (hiPSC)-derived
Georg Rast et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2015)
Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation
Tadashi Miyamoto et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Dual Optical Recordings for Action Potentials and Calcium Handling in Induced Pluripotent Stem Cell Models of Cardiac Arrhythmias Using Genetically Encoded Fluorescent Indicators
LouJin Song et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1
Rosalie M. E. Meijer van Putten et al.
FRONTIERS IN PHYSIOLOGY (2015)
A Non-invasive Platform for Functional Characterization of Stem-Cell-Derived Cardiomyocytes with Applications in Cardiotoxicity Testing
Mahnaz Maddah et al.
STEM CELL REPORTS (2015)
Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes
Jan David Kijlstra et al.
STEM CELL REPORTS (2015)
Kv11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv11.1 (hERG) inhibitors
Z. Yu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Personalized Genomes and Cardiovascular Disease
Kiran Musunuru
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Action Potential Characterization of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using Automated Patch-Clamp Technology
Olaf Scheel et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
Ashish Mehta et al.
CARDIOVASCULAR RESEARCH (2014)
Genetically Encoded Ca2+ Indicators in Cardiac Myocytes
Lars Kaestner et al.
CIRCULATION RESEARCH (2014)
AKAP9 Is a Genetic Modifier of Congenital Long-QT Syndrome Type 1
Carin P. de Villiers et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery
Tomo Saric et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Irene C. Turnbull et al.
FASEB JOURNAL (2014)
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation
Marc N. Hirt et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology
Tomohiro Hayakawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander et al.
NATURE BIOTECHNOLOGY (2014)
All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins
Daniel R. Hochbaum et al.
NATURE METHODS (2014)
Chemically defined generation of human cardiomyocytes
Paul W. Burridge et al.
NATURE METHODS (2014)
Monolayer culturing and cloning of human pluripotent stem cells on laminin-521-based matrices under xeno-free and chemically defined conditions
Sergey Rodin et al.
NATURE PROTOCOLS (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Jun Lu et al.
PLOS ONE (2014)
Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue
Miao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Selection Via Pluripotency-Related Transcriptional Screen Minimizes the Influence of Somatic Origin on iPSC Differentiation Propensity
Katherine A. Hartjes et al.
STEM CELLS (2014)
Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation
Yumiko Nozaki et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Optical mapping of optogenetically shaped cardiac action potentials
Sarah A. Park et al.
SCIENTIFIC REPORTS (2014)
Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells
Allen Chen et al.
STEM CELL RESEARCH & THERAPY (2014)
Three-Dimensional Paper-Based Model for Cardiac Ischemia
Bobak Mosadegh et al.
ADVANCED HEALTHCARE MATERIALS (2014)
An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decisionmaking
Rhian McNaughton et al.
BMJ OPEN (2014)
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
Henrik Svanstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents
John K. Gibson et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Subarna Bhattacharya et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Computational Models of Ventricular- and Atrial-Like Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
Michelangelo Paci et al.
ANNALS OF BIOMEDICAL ENGINEERING (2013)
Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
Ping Liang et al.
CIRCULATION (2013)
Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier Against Arrhythmic Risk in Long-QT Syndrome
Sabine Duchatelet et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
Milena Bellin et al.
EMBO JOURNAL (2013)
Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells
Dongrui Ma et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Improvement of Electrical Stimulation Protocol for Simultaneous Measurement of Extracellular Potential with On-Chip Multi-Electrode Array System
Tomoyuki Kaneko et al.
JAPANESE JOURNAL OF APPLIED PHYSICS (2013)
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics
Cecile Terrenoire et al.
JOURNAL OF GENERAL PHYSIOLOGY (2013)
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes
Sara S. Nunes et al.
NATURE METHODS (2013)
Multi-electrode array technologies for neuroscience and cardiology
Micha E. Spira et al.
NATURE NANOTECHNOLOGY (2013)
Assessing cardiovascular drug safety for clinical decision-making
Raymond L. Woosley et al.
NATURE REVIEWS CARDIOLOGY (2013)
Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
Alexandra Bizy et al.
STEM CELL RESEARCH (2013)
Concise Review: Maturation Phases of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Claire Robertson et al.
STEM CELLS (2013)
Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem CellDerived Cardiomyocytes to Functional Preclinical Safety Assays
Kate Harris et al.
TOXICOLOGICAL SCIENCES (2013)
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
E. Di Pasquale et al.
CELL DEATH & DISEASE (2013)
Electrical Stimulation Promotes Maturation of Cardiomyocytes Derived from Human Embryonic Stem Cells
Yau-Chi Chan et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2013)
MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
James Kramer et al.
SCIENTIFIC REPORTS (2013)
Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: Effects of reference compounds
Herbert M. Himmel
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Quantitative comparison of cardiac ventricular myocyte electrophysiology and response to drugs in human and nonhuman species
Thomas O'Hara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture
Adam W. Feinberg et al.
BIOMATERIALS (2012)
Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes
Michelangelo Paci et al.
BIOMEDICAL ENGINEERING ONLINE (2012)
Personalized medicine and the role of induced pluripotent stem cells
Marcel A. G. van der Heyden et al.
CARDIOVASCULAR RESEARCH (2012)
Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease
Richard P. Davis et al.
CIRCULATION (2012)
Optical Imaging of Voltage and Calcium in Cardiac Cells & Tissues
Todd J. Herron et al.
CIRCULATION RESEARCH (2012)
Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes A Methods Overview
Christine L. Mummery et al.
CIRCULATION RESEARCH (2012)
Practice and challenges of thorough QT studies
Norman Stockbridge et al.
JOURNAL OF ELECTROCARDIOLOGY (2012)
Induced pluripotent stem cells: the new patient?
Milena Bellin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Modulation of hERG potassium channel gating normalizes action potential duration prolonged by dysfunctional KCNQ1 potassium channel
Hongkang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Quickly finding a needle in a haystack: A new automated cardiac arrhythmia detection software for preclinical studies
Florence Koeppel et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythrnias
Maaike Hoekstra et al.
FRONTIERS IN PHYSIOLOGY (2012)
Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform
Anupama Natarajan et al.
BIOMATERIALS (2011)
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
H. G. Laverty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
Elena Matsa et al.
EUROPEAN HEART JOURNAL (2011)
Pharmacological Activation of Kv11.1 in Transgenic Long QT-1 Rabbits
Bo Hjorth Bentzen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Modelling the long QT syndrome with induced pluripotent stem cells
Ilanit Itzhaki et al.
NATURE (2011)
Getting pharmaceutical R&D back on target
Mark E. Bunnage
NATURE CHEMICAL BIOLOGY (2011)
A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability
Paul W. Burridge et al.
PLOS ONE (2011)
Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation
Thomas O'Hara et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Functional Cardiotoxicity Profiling and Screening Using the xCELLigence RTCA Cardio System
Biao Xi et al.
JALA (2011)
Cell Communications in the Heart
Daniela Tirziu et al.
CIRCULATION (2010)
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Adriana Albini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditionsa comparison of multiple cell lines
Mari Pekkanen-Mattila et al.
ANNALS OF MEDICINE (2009)
Anthropomorphizing the Mouse Cardiac Action Potential via a Novel Dynamic Clamp Method
Rebecca C. Ahrens-Nicklas et al.
BIOPHYSICAL JOURNAL (2009)
QTc: how long is too long?
J. N. Johnson et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2009)
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
Jules C. Hancox et al.
PHARMACOLOGY & THERAPEUTICS (2008)
The clinical role of genetic polymorphisms in drug-metabolizing enzymes
D. Tomalik-Scharte et al.
PHARMACOGENOMICS JOURNAL (2008)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Genotype-specific onset of arrhythmias in congenital long-QT syndrome - Possible therapy implications
Hanno L. Tan et al.
CIRCULATION (2006)
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics
Daniel W. Nebert et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Mapping arrhythmias in the failing heart: from Langendorff to patient
Joseph G. Akar et al.
JOURNAL OF ELECTROCARDIOLOGY (2006)
hERG potassium channels and cardiac arrhythmia
MC Sanguinetti et al.
NATURE (2006)
Drug binding interactions in the inner cavity of hERG channels: Molecular insights from structure-activity relationships of clofilium and ibutilide analogs
M Perry et al.
MOLECULAR PHARMACOLOGY (2006)
Animal models for arrhythmias
DJ Milan et al.
CARDIOVASCULAR RESEARCH (2005)
Drugs, QTc interval prolongation and final ICH E14 guideline - An important milestone with challenges ahead
RR Shah
DRUG SAFETY (2005)
Studying cardiac arrhythmias in the mouse - A reasonable model for probing mechanisms?
JM Nerbonne
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
QT variability
RD Berger
JOURNAL OF ELECTROCARDIOLOGY (2003)
Cardiotoxicity of fluoroquinolones
E Rubinstein et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Tissue engineering of a differentiated cardiac muscle construct
WH Zimmermann et al.
CIRCULATION RESEARCH (2002)
The genetic basis of variability in drug responses
DM Roden et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
分享论文
